ANTIRETROVIRAL THERAPY

This publication has 73 references indexed in Scilit:

• Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
  New England Journal of Medicine, 1996
• In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
  Nature, 1995
• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
  New England Journal of Medicine, 1994
• Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
  The Lancet, 1994
• A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1994
• High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase
  Antimicrobial Agents and Chemotherapy, 1993
• Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive Subjects
  The Journal of Infectious Diseases, 1992
• Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine
  The American Journal of Medicine, 1991
• A Pilot Study of Low-Dose Zidovudine in Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• Pharmacodynamics of 2′,3′-dideoxycytidine: An inhibitor of human immunodeficiency virus
  The American Journal of Medicine, 1990